This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.00% per year. These returns cover a period from January 1, 1988 through May 4, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
UnitedHealth Group, Inc. is the largest health care services company in the world, serving over 50 million individuals in the United States as of 2019 and over 5 million internationally. The company provides a wide range of health care products and services, such as health maintenance organizations (HMOs), point of service plans (POS), preferred provider organizations (PPOs), and managed fee-for-service programs. UnitedHealth has the largest and most diverse membership base within the managed-care organization market, which gives it significant competitive advantages. It also has built its prescription drug business through OptumRx division, with the acquisition of Catamaran in 2015.
Top Stock Reports for Micron Technology, Roche & UnitedHealth
by Mark Vickery
MU leads today's Zacks Research Daily, with AI-driven memory demand, strong DRAM pricing recovery and solid cash flow powering recent outperformance.
Company News for Jan 7, 2026
by Zacks Equity Research
Companies in The News Are: XOM, AIG, STX, UNH
Centene Jumps 16.3% in 3 Months: A Comeback or Calm Before the Storm?
by Kaibalya Pravo Dey
CNC shares jump 16.3% in three months, but high medical costs and thin margins keep the recovery debate alive.
UnitedHealth Sinks 34.5% in a Year: Buy the Dip Before Q4 Earnings?
by Kaibalya Pravo Dey
UNH shares are down 34.5% in a year as costs and margins bite, with Q4 earnings and 2026 guidance set to test whether value is emerging.
Why UnitedHealth Group (UNH) Outpaced the Stock Market Today
by Zacks Equity Research
In the most recent trading session, UnitedHealth Group (UNH) closed at $336.4, indicating a +1.91% shift from the previous trading day.
UNH vs. ELV: Which Managed Care Stock Has the Edge Today?
by Rajshree Sipani
Elevance Health is edging past UnitedHealth as Carelon's growth, strategic exits and a cheaper valuation shape a stronger near-term setup.
Why Humana Deserves Patience Now: Too Early to Buy, Too Risky to Sell
by Zacks Equity Research
HUM sits at a crossroads as Medicare Advantage pressures cap near-term upside, but resilience versus peers argues for patience, not panic.
UnitedHealth Group (UNH) Advances While Market Declines: Some Information for Investors
by Zacks Equity Research
In the latest trading session, UnitedHealth Group (UNH) closed at $331.83, marking a +1.3% move from the previous day.
AI Takes Center Stage at UNH: Will It Fix Administrative Waste?
by Zacks Equity Research
UnitedHealth puts AI at the core of its strategy to cut administrative waste, speed claims and approvals, and protect margins amid rising healthcare complexity.
eHealth's Guidance Update: Here's What a Strong AEP Signals
by Kaibalya Pravo Dey
EHTH raises its 2025 outlook after a steady AEP, lifting revenue and EBITDA forecasts as Medicare performance and efficiency improve.